✦ LIBER ✦

P.2.c.027 The relevance of treating painful somatic symptoms to functional outcome improvement in patients with major depressive disorder

✍ Scribed by T.N. Wise; A.L. Meyers; D. Desaiah; C. Mallinckrodt; M.J. Robinson; D.K. Kajdasz

Book ID: 118593947
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 59 KB
Volume: 17
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(07)70519-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.038 Efficacy of levomilnacipran in

P.2.c.038 Efficacy of levomilnacipran in improving symptoms and functional impairment associated with major depressive disorder

✍ Y. Lecrubier; L. Mansuy; A. Bose; J. Li; P. Werner 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

P.2.c.027 Inverse correlation between pl

P.2.c.027 Inverse correlation between plasma levels of the endocannabinoid, 2-arachidonylglycerol, and severity of symptoms in patients with major depression

✍ D. Xenos; M. Marconi; E. Caroti; V. Cuoco; A. Quartini; F. Weisz; F. Fanelli; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.2.c.034 Escitalopram versus nortriptyl

P.2.c.034 Escitalopram versus nortriptyline in the treatment of painful physical symptoms in patients with major depression

✍ K. Gattner; J. Jaracz; J. Hauser 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Assessment of depressive symptoms and fu

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

✍ Tina Marie Myers Oakes; Adam L. Myers; Lauren B. Marangell; Jonna Ahl; Apurva Pr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 3 views

Objective Return of functional ability is a central goal in the treatment of major depressive disorder. We conducted two trials with the same protocol that was designed to assess functioning after 8 Weeks of treatment with duloxetine. Methods The a priori primary outcome was improvement in the Hamil

P.2.c.033 The efficacy of desvenlafaxine

P.2.c.033 The efficacy of desvenlafaxine for improving functioning and quality of life measures in patients with major depressive disorder

✍ C. Soares; M. Thase; S. Kornstein; C. Brisard; L. Septien-Velez; J.M. Germain; B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB